GW Pharmaceuticals PLC Holding(s) in Company (8577E)
21 July 2016 - 7:04PM
UK Regulatory
TIDMGWP
RNS Number : 8577E
GW Pharmaceuticals PLC
21 July 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
----------------------------------------------------------------------------------------------------
1. Identity of the issuer or GW Pharmaceuticals plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
-------------------------------------------------------------- ------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------ --------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------ --------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------ --------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------ --------------------------------
Other (please
specify):
-------------------------------------------------------- -------- --------------------------------
3. Full name of person(s) The Capital Group Companies,
subject to the Inc.
notification obligation:
(iii)
---------------------------------------------------------- ----------------------------------------
4. Full name of shareholder(s) See Section 9
(if different from 3.):(iv)
---------------------------------------------------------- ----------------------------------------
5. Date of the transaction 15 July 2016
and date on
which the threshold is
crossed or
reached: (v)
---------------------------------------------------------- ----------------------------------------
6. Date on which issuer 18 July 2016
notified:
---------------------------------------------------------- ----------------------------------------
7. Threshold(s) that is/are Above 15% - Aggregate of voting
crossed or rights from shares
reached: (vi, vii)
---------------------------------------------------------- ----------------------------------------
8. Notified details:
-------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
-------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
--------------------- -------------------------------- ----------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
--------------------- --------------- --------------- ------------- ---------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--------------------- ----------- ----------- ------------- --------- ----------- ------------ -----------
ADSs
(ISIN: US36197T1034) 3,253,847 39,046,164 39,885,288 15.1652%
--------------------- --------------- --------------- ------------- --------- ----------- ------------ -----------
B: Qualifying Financial Instruments
-------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------------- ------------- ------------------------------ ------------------------ ---------------------
Not applicable
------------------------- ------------- ------------------------------ ------------------------ ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-------------------------------------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
----------------------- ------------- ------------- --------------- ------------------------ -----------------------
Not applicable Nominal Delta
----------------------- ------------- ------------- --------------- ------------------------ ------------ ---------
Total (A+B+C)
-------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------------------------- --------------------------------------------------------------
39,885,288 15.1652%
--------------------------------------------------------- --------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
---------------------------------------------------------------------------------------------------
Number of Percent
Shares of Outstanding
The Capital Group Companies, Inc.
("CG") holdings 39,885,288 15.1652%
Holdings by CG Management Companies
and Funds:
------------------------------------------- ----------- ----------------
-- Capital Research and Management
Company(1) 39,885,288 15.1652%
* SMALLCAP World Fund, Inc.(2) 20,738,400 7.8852%
(1) Subsidiary of The Capital Group Companies, Inc.
(2) Mutual fund managed by Capital Research and Management
Company.
---------------------------------------------------------------------------------------------------
Proxy Voting:
---------------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------------------------ -------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------------------------ -------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------------------------ -------------------
13. Additional information:
------------------------------------------------------------------------------ -------------------
14. Contact name: Christopher Aquino
------------------------------------------------------------------------------ -------------------
15. Contact telephone number: (213) 615-0469
------------------------------------------------------------------------------ -------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAPXFASNKEEF
(END) Dow Jones Newswires
July 21, 2016 05:04 ET (09:04 GMT)
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More GW Pharm. News Articles